China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

SZSE:000999.SZ

43 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 24,464.0518,079.46115,319.99413,637.25814,701.91913,427.74611,119.9168,981.7217,900.197,276.5867,801.6046,891.1035,525.2234,365.1534,852.7174,316.1873,397.8442,867.9262,969.4742,461.6862,674.4552,165.6781,867.3151,828.0581,476.4191,425.8791,109.838
Cost of Revenue 11,859.6898,313.1346,170.8435,119.6154,830.0734,160.3623,907.7423,362.2663,067.032,812.1813,089.8712,678.2152,267.3891,686.2292,396.0652,352.8681,780.8581,551.4351,559.2481,363.5011,353.8571,103.311916.9971,005.252635.446604.724487.214
Gross Profit 12,604.3619,766.3289,149.1518,517.6439,871.8469,267.3847,212.1755,619.4554,833.164,464.4054,711.7334,212.8883,257.8342,678.9252,456.6521,963.3191,616.9861,316.4911,410.2271,098.1851,320.5981,062.367950.317822.807840.973821.155622.624
Gross Profit Ratio 0.5150.540.5970.6250.6710.690.6490.6260.6120.6140.6040.6110.590.6140.5060.4550.4760.4590.4750.4460.4940.4910.5090.450.570.5760.561
Reseach & Development Expenses 641.518593.942560.202459.844441.876355.844297.335286.788236.462231.8198.37159.646102.9571.5530000000000000
General & Administrative Expenses 351.364253.992253.814236.946237.203175.941168.777156.561145.05125.145177.279141.738111.52183.655367.632311.342221.281241.498328.468768.248389.952396.97443.737263.116156.685224.536203.539
Selling & Marketing Expenses 6,965.4755,076.6245,021.3065,015.1556,550.2766,468.6064,750.1693,279.532,677.2832,412.6832,410.212,199.2231,758.9531,355.6731,165.87960.688814.865639.387695.073601.877502.915357.571348.394345.809445.435421.809268.351
SG&A 8,330.6235,330.6165,275.1215,252.1016,787.4796,644.5484,918.9463,436.0912,822.3332,537.8282,587.4892,340.9611,870.4741,439.3271,533.5031,272.0311,036.146880.8861,023.541,370.125892.868754.541792.131608.925602.12646.345471.89
Other Expenses -108.172792.478662.24625.095678.32615.4027.793175.47491.91639.09725.73475.38128.174.15422.21316.50759.741-13.1028.453-9.7714.5439.18847.44359.34952.22946.35445.948
Operating Expenses 9,080.3146,717.0356,497.5626,337.047,907.6817,550.3445,661.0584,291.1593,555.8473,243.6673,291.2112,950.2022,325.6681,759.1321,553.851,309.4871,051.556894.4191,036.5371,380.556909.95764.351797.312616.062605.241649.491474.887
Operating Income 3,524.0472,947.2182,457.4462,070.182,529.4261,703.4781,510.5141,293.7271,442.5661,228.0311,411.7891,262.106926.838962.631884.966634.994325.569258.094193.268-649.817279.791185.678126.72196.25208.264143.24298.518
Operating Income Ratio 0.1440.1630.160.1520.1720.1270.1360.1440.1830.1690.1810.1830.1680.2210.1820.1470.0960.090.065-0.2640.1050.0860.0680.1070.1410.10.089
Total Other Income Expenses Net 225.20216.218-28.39-10.76139.2031.841-32.81124.905251.6938.86812.45220.09715.947114.2331.655-7.836-181.002-249.693-226.403-417.052-149.244-114.46513.38234.50323.63217.273-3.979
Income Before Tax 3,749.2492,963.4362,429.0562,059.4192,568.631,718.881,518.3071,453.2011,529.0031,259.6051,432.9741,282.783948.1121,034.026904.456645.996384.427208.686174.503-679.505272.869189.208170.275248.423259.928189.267144.111
Income Before Tax Ratio 0.1530.1640.1590.1510.1750.1280.1370.1620.1940.1730.1840.1860.1720.2370.1860.150.1130.0730.059-0.2760.1020.0870.0910.1360.1760.1330.13
Income Tax Expense 580.975466.425348.219441.89429.547244.009191.83245.442254.304187.463218.343201.693132.986174.923142.866104.854100.33442.1359.92339.31149.8435.75946.13942.66629.45830.20128.629
Net Income 2,852.9322,448.8022,055.1041,597.4892,112.4951,432.0781,301.6871,197.8411,249.2271,035.8891,181.1051,014.076760.448815.985709.489500.087279.797164.922119.934-720.797208.795165.02121.027201.579220.219150.83298.804
Net Income Ratio 0.1170.1350.1340.1170.1440.1070.1170.1330.1580.1420.1510.1470.1380.1870.1460.1160.0820.0580.04-0.2930.0780.0760.0650.110.1490.1060.089
EPS 2.912.52.11.632.141.461.331.221.281.061.131.040.780.830.720.510.290.220.12-0.740.210.170.120.160.220.150.1
EPS Diluted 2.912.52.11.632.141.461.331.221.281.061.131.040.780.830.720.510.290.220.12-0.740.210.170.120.160.220.150.1
EBITDA 4,377.7593,651.1733,186.9312,712.7743,160.2612,133.9641,899.5371,829.531,820.7921,562.3521,709.5771,585.111,122.2881,154.9781,048.748771.15722.023491.077451.887-385.525526.86425.035380.562420.744290.508171.02176.741
EBITDA Ratio 0.1790.2020.2080.1990.2150.1590.1710.2040.230.2150.2190.230.2030.2650.2160.1790.2120.1710.152-0.1570.1970.1960.2040.230.1970.120.159